Berlin Institute of Health (BIH)

In the Berlin Institute of Health (BIH), the Max Delbrück Center for Molecular Medicine (MDC) and the Charité - Universitätsmedizin Berlin have joined forces. Our core idea is to combine translational research with an overarching systems medicine approach to bridge the gap between basic research and clinical application. We are bringing these two worlds of science together in a shared research space, since close exchange between experimental research and medical practice is crucial when it comes to developing improved diagnostic, therapeutic, and preventive procedures for the sake of human health.

The BIH was founded in March 2013 as an internal GbR (a partnership under civil law) and has become a Körperschaft des öffentlichen Rechts (corporation under public law) in 2015. As cooperating partners the MDC and Charité will keep their status as separate legal entities and thus retain full independence.



If you would like to be kept informed about the latest developments and funding opportunities at the BIH, you can subscribe to our mailing list.